Sovereign Pharmaceuticals Becomes First Manufacturer to Earn All GS1 EPCIS Trustmarks for FDA DSCSA Interoperability Mandate
Drummond Group & Vantage Consulting Key Partners in Sovereign’s Implementation of Drummond Certified™ QU4RTET Track and Trace Solution
This content was submitted directly to this website by the supplier.
Mar 8th, 2021
Drummond Group LLC, provider software compliance and interoperability testing, announced validation of Sovereign Pharmaceuticals’ implementation for compliance to all seven GS1 US Rx Electronic Product Code Information Services (EPCIS) Conformance Testing scenarios for manufacturers.
With Vantage Consulting Group’s guidance as a key partner, Sovereign utilized QU4RTET 3.0 to meet the requirements of the Drug Supply Chain Security Act (DSCSA) that ensures the FDA and law enforcement agencies may securely detect stolen, contaminated or counterfeit drugs. In 2020, Vantage first completed Drummond EPCIS Cerification testing of QU4R
Sovereign Pharmaceuticals Becomes First Manufacturer to Earn All GS1 EPCIS Trustmarks for FDA DSCSA Interoperability Mandate
Share Article
Drummond Group & Vantage Consulting Key Partners in Sovereign’s Implementation of Drummond Certified™ QU4RTET Track and Trace Solution
“Successfully passing all seven GS1 EPCIS Conformance Testing scenarios is a major accomplishment. Drummond commends Sovereign and Vantage on this partnership and success.” PORTSMOUTH, N.H. (PRWEB) February 25, 2021
Drummond Group LLC, a trusted leader in software compliance and interoperability testing, today announced validation of Sovereign Pharmaceuticals’ implementation for compliance to all seven GS1 US Rx Electronic Product Code Information Services (EPCIS) Conformance Testing scenarios for manufacturers. With Vantage Consulting Group’s guidance as a key partner, Sovereign utilized QU4RTET 3.0 to meet the requirements of the
Despite COVID, Spanish Retailer Rolls Out RFID Across 125 Stores in One Month February 24, 2021 at 10:07 AM EST By Claire Swedberg, RFID Journal
Share on linkedin
Spanish fashion retailer
Encuentro Moda is deploying a radio frequency identification solution across its
125 stores, both to meet omnichannel requirements and to gain visibility into the stock availability at each store and throughout the supply chain. The rollout, which began in September 2020, was completed within only four weeks, according to Nedap, the technology provider. The retailer has achieved stock accuracy of
98% at the first store in which the technology was deployed, and it is still measuring other potential gains, such as sales lifts due to merchandise availability and the ability to provide goods to online shoppers more quickly.
6 Things We Need From FDA Before Full 2023 DSCSA Enforcement
By Mike Karhoff and Mark Karhoff, Ten Count Consulting, LLC
The journey to industry compliance with the U.S. Drug Supply Chain Security Act (DSCSA) continues to twist and turn with recent requirements going into effect for distributors and dispenser and subsequent delays on enforcement of some of those requirements until Nov. 27, 2023. While the FDA did well to respond to requests for delays in enforcement, the postponement does not remove the active requirements of the law, and stakeholders should continue to work towards ensuring compliance and documenting their efforts in the event of potential FDA inquires or investigations. It is important to continue working on these systems and communicating with trading partners to mitigate risk and take advantage of the opportunity to stabilize systems, processes, and data.